Document is current
Any future updates will be listed below
-
Authors
Lapi, Francesco https://orcid.org/0000-0002-4342-9128
Marconi, Ettore
Medea, Gerardo
Grattagliano, Ignazio
Rossi, Alessandro
Cricelli, Claudio
-
Funding
Funding for this research was provided by:
Pfizer
- License Information
-
More Information
Article History
Received: 19 October 2024
Accepted: 10 January 2025
First Online: 24 January 2025
Declarations
:
: The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: FL and EM provided consultancy for protocol preparation for epidemiological studies and data analyses for GSK, Pfizer, Moderna, Sanofi, MSD and Seqirus. GM, IG, AR, and CC provided clinical consultancy for GSK, Pfizer, Moderna, Sanofi, MSD and Seqirus.
: The study protocol was approved by the Scientific Committee of the Italian College of General Practitioners and Primary Care. This study followed the principles of the Declaration of Helsinki and complied with the ENCePP Guide on Methodological Standards in Pharmacoepidemiology.
: For this type of study, formal consent is not required.
